Debra Yu joins Panacea as partner, COO

Debra Yu joined Panacea Venture as partner and COO. Yu, who also recently joined the board of JW Therapeutics Co. Ltd. (HKEX:2126), was president and chief strategy officer of Perceptive Advisors’ cross-border biotech LianBio (NASDAQ:LIAN). Prior to that, Yu was managing director and head of cross-border healthcare investment banking for China Renaissance and managing director at Labrador.

Flagship Pioneering-backed  Sonata Therapeutics Inc. hired Francesco Marincola as CSO. Marincola was SVP and global head of cell therapy research at Kite Pharma, now part of Gilead Sciences Inc. (NASDAQ:GILD). The company is focusing on the cellular microenvironment as an inroad into cancer, fibrosis and autoimmune disorders...